We are very pleased to announce that - as foreshadowed in our technical updates and primarily in response to CMA advocacy on this issue - the fee free period for transitioning ARTG listings to permitted indications has formally been extended for 18 months to 6 March 2021 - the final date that medicines can transition before auto-cancellation - and this fee-free information update has now been published on the TGA website.

As noted previously, there was a very short period after 6 September 2019 where the legislation was not yet in effect and if you received an invoice, this will need to be paid and then refunded.

We would like to thank all our members for your ongoing support and involvement.

Team CMA.